Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA-Seq transcriptome analysis of renal tissue from spontaneously hypertensive rats revealed renal protective effects of dapagliflozin, an inhibitor of sodium-glucose cotransporter 2
Jiangjun Wei, Fangyan Tan, Xianglin Long, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 189, pp. 106531-106531
Open Access | Times Cited: 10

Showing 10 citing articles:

Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 956-956
Open Access | Times Cited: 4
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors ameliorate renal ischemia-reperfusion injury (IRI) by modulating autophagic processes
Mengmeng Liu, Yuanqing Yao, Fangyan Tan, et al.
Translational research (2025) Vol. 277, pp. 27-38
Closed Access
LATS1-modulated ZBTB20 perturbing cartilage matrix homeostasis contributes to early-stage osteoarthritis
Xue Hao, Jing Zhao, Liyuan Jia, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
RNA-Seq transcriptomic landscape profiling of spontaneously hypertensive rats treated with a sodium-glucose cotransporter 2 (SGLT2) inhibitor
Fangyan Tan, Xianglin Long, Jianlin Du, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115289-115289
Open Access | Times Cited: 9
Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Jia Liu, Xiaona Chang, Xiaoyu Ding, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Sodium Glucose Co-transporter 2 Inhibitors: Pharmacology, Mechanism of Action and Efficacy in Non-diabetic Kidney Disease from Bench to Bed-Side
Aly M. Abdelrahman, Alaa S. Awad, Emaad M. Abdel‐Rahman
(2024)
Open Access | Times Cited: 1
Inhibition of Renin Expression Is Regulated by an Epigenetic Switch From an Active to a Poised State
Jason P. Smith, Robert Paxton, Silvia Medrano, et al.
Hypertension (2024) Vol. 81, Iss. 9, pp. 1869-1882
Closed Access | Times Cited: 1
Epigenetics of Hypertensive Nephropathy
Yize Zhang, Hamidreza Arzaghi, Zhehan Ma, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2622-2622
Open Access
Oxidative Stress in Kidney Injury and Hypertension
William J. Arendshorst, Aleksandr E. Vendrov, Nitin Kumar, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1454-1454
Open Access
Protein Kinase A Inhibition Epigenetically SilencesRen1
Jason P. Smith, Robert Paxton, Silvia Medrano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top